Plasticity Product is a term coined by Jerry Rudy to refer to mRNA genetic artifacts and protein products triggered by transcription factors leading to long-lasting long term potentiation.
Contents
Introduction
The term "plasticity product" was coined by Jerry Rudy to refer to mRNA genetic artifacts and protein products triggered by transcription factors, leading long-lasting long term potentiation (L-LTP) and sustained alterations in synaptic strength.
Rudy differentiates between two types of long term potentiation: S-LTP (short-lasting) and L-LTP (long-lasting). In S-LTP the stimulus is strong enough to induce long-term potentiation but too weak to trigger intracellular events necessary to sustain synaptic changes. L-LTP is much less transient than S-LTP and involves the generation of new proteins through translation and transcription.
Induction of L-LTP depends on the transcription of new mRNA and the translation of these new mRNA into proteins. These steps are encompassed by the genomic signaling hypothesis as follows:
- A stimulus is strong enough to induce L-LTP is delivered.
- A signaling cascade begins, leading to phosphorylation of transcription factors.
- mRNA is produced leading to subsequent translation of new proteins to sustain synaptic changes.
Support for the genomic signaling hypothesis comes from studies conducted by Nguyen et al. demonstrating the inability to induce L-LTP following transcription inhibition immediately following the inducing stimulus but not if transcription is blocked later. The temporal effects of this inhibition suggests that L-LTP is dependent on newly synthesized "plasticity products."
cAMP-responsive element-binding (CREB) protein, a transcription factor, is also implicated in changes in synaptic plasticity. Inhibition of CREB translation likewise inhibited synaptic changes. CREB is activated in its phosphorylated form, acting as a molecular switch for production of plasticity products.
Two Waves of Protein Synthesis
There are two waves of protein synthesis following LTP induction. The first involves local transcription and translation of mRNA and the second involves the genomic signaling cascade.
Transcription and Local Translation of mRNAs
There is fast-acting, local translation of proteins in the dendritic region near the spines when an inducing high-frequency stimulus is applied, indicating that some plasticity-relevant mRNAs are already present and ready to be translated. To facilitate translation outside of the soma, since synapses depend on some proteins to be synthesized on site, translation machinery such as ribosomal assemblies and endoplasmic reticulum are present in dendrites (specifically in the spine neck and shaft). Local protein synthesis at the dendrites is a mechanism permitting rapid synaptic changes in response to neural activity. However, since the mRNAs existed in the dendrites prior to plasticity-inducing stimulation, they do not count as plasticity products.Genomic Signaling Cascade
A synapse-to-nucleus or soma-to-nucleus signaling cascade induced by synaptic activity leads to the transcription of new plasticity products in the soma of the cell. Mechanistically, signaling molecules phosphorylate cAMP-responsive element binding protein (CREB), which is a transcription factor and molecular memory switch that initiates production of mRNAs in the cell nucleus. These plasticity products must then travel back to activated synapses, meaning that this wave of plasticity product synthesis is slower.Examples of Plasticity Products
A plasticity product must fit these criteria:
a) Plasticity products are proteins that are important for the maintenance of long-lasting LTP. b) Plasticity products result from any cell-signaling cascade that is triggered by strong HFS.